Monument Therapeutics
Developer of novel drugs intended to treat serious diseases of the central nervous system. The company's approach utilizes proprietary digital biomarkers to reduce heterogeneity and identify patients ...
Valuation
$12.7M
Market implied
Share Price
N/A
Total Raised
$8.6M
Last Round
N/A